P2.16-10 Prognostic Impact of Postoperative C-Reactive Protein for Non-Small Cell Lung Cancer Following Lobectomy

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1485
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P2.16-44 Long-Term Outcome of Pulmonary Segmentectomy for C-Ia Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Postoperative Radiotherapy for Non-Small Cell Lung Cancer

2005English

Postoperative Blood Transplantation for Non-Small Cell Lung Cancer

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2019English

P1.16-52 Long-Term Impact of Postoperative Complications Following Lung Resection Among Patients With Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Prognostic Gene Signatures for Non-Small-Cell Lung Cancer

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

P2.16-28 Comparison of Outcomes of VATS Segmentectomy Versus Lobectomy for Non-Small Cell Lung Cancer Using a Propensity Score Matching Analysis

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.16-20 Prognostic Utility of PET in Non-Small Cell Lung Cancer After Empiric Stereotactic Body Radiotherapy (SBRT)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Long Term Results of Vats Lobectomy Versus Opened Lobectomy for Early Stage Non Small Cell Lung Cancer

Respirology
PulmonaryRespiratory Medicine
2019English

Adverse Prognostic Impact of TGFB1 T869C Polymorphism in Non-Small-Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy